Trademarkia Logo

Canada

C$
ARTERY DESIGN
FORMALIZED

on 3 Jul 2024

Last Applicant/ Owned by

KOWA COMPANY, LTD.

6-29, Nishiki 3-chome,Naka-ku, Nagoya-shiAichi-ken 460-8625

JP

Serial Number

2336641 filed on 3rd Jun 2024

ARTERY DESIGN

Trademark usage description

pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases of the circulatory system and diabetes-related diseases Read More

Vienna Information


1 . 15 . 15

DropsGouttes

2 . 9 . 25

Other parts of the human body -- Notes: (a) Including human or animal sperm. (b) Not including heads, which will be placed in the appropriate sections of divisions 2.1, 2.3, 2.5 or 2.7.Autres parties du corps humain -- Notes: Y compris le sperme humain ou animal. (b) Non compris les têtes qui seront rangées dans les sections appropriées des divisions 2.1, 2.3, 2.5 ou 2.7.

25 . 7 . 20

Surfaces or backgrounds covered with lines or bandsSurfaces ou fonds couverts de lignes ou de bandes

25 . 7 . 21

Surfaces or backgrounds covered with straight lines or bandsSurfaces ou fonds couverts de lignes ou de bandes droites

26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 9

Oblique lines or bandsLignes ou bandes obliques

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

26 . 11 . 13

Wavy lines or bands, zigzag lines or bandsLignes ou bandes ondulées, en dents de scie

26 . 15 . 1

SpheresSphères

26 . 15 . 3

CylindersCylindres

27 . 1 . 1

Letters or numerals forming geometrical figures, written or typographical matter in perspectiveLettres ou chiffres formant des figures géométriques, inscriptions en perspective

27 . 1 . 25

Letters or numerals forming some other geometrical figureLettres ou chiffres formant une autre figure géométrique

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 2

Letters or numerals representing a human being or a part of the human bodyLettres ou chiffres représentant un être humain ou une partie du corps humain

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 3

Letters in relief or shadedLettres en relief ou ombrées

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

27 . 5 . 21

One letterUne lettre

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 4

BlueBleu

29 . 1 . 2

Yellow, goldJaune, or

Classification Information


Class [005]
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, pharmaceutical preparations for treatment of fatty liver and steatohepatitis, pharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorders, pharmaceutical preparations for the treatment of digestive system disease, pharmaceutical preparations for the treatment of primary biliary cirrhosis, pharmaceutical preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, pharmaceutical preparations for the treatment of liver disease, pharmaceutical preparations for the treatment of metabolic disease, pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system, analgesics; pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; veterinary preparations, namely, veterinary preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, veterinary preparations for treatment of fatty liver and steatohepatitis, veterinary preparations for the treatment of cardiovascular disorders and metabolic disorders, veterinary preparations for the treatment of digestive system disease, veterinary preparations for the treatment of primary biliary cirrhosis, veterinary preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, veterinary preparations for the treatment of liver disease, veterinary preparations for the treatment of metabolic disease, veterinary preparations for the prevention and treatment of disorders of the metabolic system, analgesics; veterinary pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; veterinary pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; sanitary preparations for medical use; anti-inflammatory agents, namely, topical preparations in the form of gels and salves, adhesive skin patches, liquid formulations, cream and sprays, all for relieving pain.


Classification kind code

11

Mark Details


Serial Number

2336641

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 4th Jul 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 3rd Jul 2024
Created
Submitted for opposition 31
on 3rd Jul 2024
Formalized
Submitted for opposition 30
on 3rd Jun 2024
Filed
Submitted for opposition 228
on 18th Mar 2022
International Registration